Evaluation of the Impact of the Use of NewSpringForMe on Transplanted Patients' Quality of Life and Support
Conditions: Hematologic Diseases; Bone Marrow Transplantation; Hematopoietic Stem Cell Transplantation Interventions: Device: NewSpringForMe digital solution Sponsors: Fonds de Dotation HTC Project; Saint-Louis Hospital, Paris, France; Nutricia Nutrition Clinique; Clinicprosport; ELLYE; Association A ïda; Gilead Sciences; Pfizer; Groupe Apicil; Association Laurette Fugain; Fondation du LEEM; Fondation AFNIC; Pierre Fabre Medicament; Novartis Pharmaceuticals; University Hospital, Clermont-Ferrand; LAPSCO, Université Clermont-Auvergne Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 28, 2023 Category: Research Source Type: clinical trials
Evaluate the Efficacy and Safety of Allogeneic Umbilical Cord Mesenchymal Stem Cells as an Add-On Treatment for Acute ST-elevation Myocardial Infarction (STEMI) Patients
Conditions: ST Elevation Myocardial Infarction Interventions: Biological: Allogeneic umbilical cord mesenchymal stem cells; Other: Control group Sponsors: Ever Supreme Bio Technology Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 28, 2023 Category: Research Source Type: clinical trials
Human Induced Pluripotent Stem Cells Derived Natural Killer Cell(XS005) Injection Combined With Stupp Regimen for Adjuvant Chemotherapy in Subjects With Primary Glioblastoma(GBM)
Conditions: Glioblastoma; GBM Interventions: Biological: XS005 Cell Injection; Drug: Temozolomide （TMZ） Sponsors: Dushu Lake Hospital Affiliated to Soochow University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 27, 2023 Category: Research Source Type: clinical trials
PRP and PBD-VSEL Stem Cell Therapy for Parkinson's Disease
Conditions: Regenerative Medicine Interventions: Biological: PRP and PBD-VSEL Stem Cell therapy Sponsors: Fatima Jinnah Medical University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for PCOS
Conditions: Polycystic Ovary Syndrome (PCOS); Polycystic Ovary Syndrome; PCOS Interventions: Biological: AlloRx Sponsors: The Foundation for Orthopaedics and Regenerative Medicine Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials
The Effects of Jing Si Herbal Tea on Physical and Psychological Symptoms in Peripheral Blood Hematopoietic Stem Cell Donors
Conditions: Pain Syndrome; Emotional Stress Interventions: Other: Jing Si Herbal Drink Sponsors: Buddhist Tzu Chi General Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 21, 2023 Category: Research Source Type: clinical trials
Randomized Phase IIa Clinical Trial in Parkinson's Disease Patients Using Pluripotent Adipose Stem Cells
Conditions: Parkinson Disease Interventions: Biological: PASC transplantation (25 million PASCs/patient); Biological: Control Sponsors: ClusterXStem-Costa Rica; Universidad de Costa Rica; University of California, Los Angeles Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 21, 2023 Category: Research Source Type: clinical trials
Randomized Clinical Trial in Parkinson's Disease Patients Using Pluripotent Adipose Stem Cells (PASCs)
Conditions: Parkinson Disease Interventions: Biological: PASC transplantation (25 million PASCs/patient); Biological: Control Sponsors: ClusterXStem-Costa Rica; Universidad de Costa Rica; University of California, Los Angeles Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 21, 2023 Category: Research Source Type: clinical trials
The Effect of GD-iExo-003 in Acute Ischemic Stroke
Conditions: Acute Ischemic Stroke Interventions: Drug: exosomes derived from human induced pluripotent stem cell for injection; Drug: a placebo of exosomes derived from human induced pluripotent stem cell for injection Sponsors: Xuanwu Hospital, Beijing; Guidon Pharmaceutics Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2023 Category: Research Source Type: clinical trials
Cytokine-induced Memory-like Natural Killer Cell Therapy After Hematopoietic Stem Cell Transplantation for Eradication of Measurable Residual Disease, a Phase I/Ib Clinical Trial
Conditions: Acute Myeloid Leukemia; Leukemia; Leukemia, Myeloid; Myelodysplastic Syndromes; Myeloproliferative Neoplasm; Myeloproliferative Disorders Interventions: Biological: Cytokine Induced Memory-like Natural Killer Cells; Biological: Interleukin-2 Sponsors: Dana-Farber Cancer Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2023 Category: Research Source Type: clinical trials
Adherence, Viability, Clinical Evolution and Therapeutic Efficacy in Patients Undergoing Bone Marrow Transplantation
Conditions: Stem Cell Transplantation Interventions: Device: Cycle ergometer; Device: Strength Training - elastic band and shin guards; Device: Cycle ergometer, elastic band and shin guards Sponsors: Federal University of Health Science of Porto Alegre Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2023 Category: Research Source Type: clinical trials
Dermogenesis With Mesenchymal Stem Cells
Conditions: Dermal Regeneration Interventions: Procedure: Autologous Mesenchymal stem cell injection Sponsors: King Edward Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2023 Category: Research Source Type: clinical trials
Autologous ADMSC Transplantation in Patients With POI
Conditions: Premature Ovarian Failure Interventions: Biological: stem cell therapy Sponsors: Mongolian National University of Medical Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 15, 2023 Category: Research Source Type: clinical trials
Decitabine and Venetoclax Treatment as Maintenance Therapy in Patients Post Allograft Stem Cell Transplant
Conditions: Myeloid Malignancy; Acute Myeloid Leukemia Interventions: Drug: Venetoclax; Drug: Decitabine Sponsors: Benjamin Tomlinson Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 13, 2023 Category: Research Source Type: clinical trials
Prospective, Single-arm, Multicenter Clinical Study on Haploidentical Hematopoietic Stem Cell Transplantation in Patients With MRD Positive CD19+ALL Treated With Conditioning Regimens Containing Blinatumomab
Conditions: Acute Lymphoblastic Leukemia Interventions: Drug: Blinatumomab Sponsors: Zhejiang University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 9, 2023 Category: Research Source Type: clinical trials
